Literature DB >> 16054239

The histamine H4 receptor as a new therapeutic target for inflammation.

Iwan J P de Esch1, Robin L Thurmond, Aldo Jongejan, Rob Leurs.   

Abstract

Following the sequencing of the human genome, data-mining efforts have revealed the existence of a new histamine receptor that is expressed at high levels in mast cells and leukocytes. The histamine H(4) receptor has a distinct pharmacological profile and the first compounds that act selectively on the H(4) receptor have been developed. Initial experiments in vivo with H(4) receptor antagonists indicate a role for the H(4) receptor in inflammatory conditions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16054239     DOI: 10.1016/j.tips.2005.07.002

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  49 in total

1.  Commercially available antibodies against human and murine histamine H₄-receptor lack specificity.

Authors:  Silke Beermann; Roland Seifert; Detlef Neumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-11-10       Impact factor: 3.000

2.  Effects of sympathetic histamine on vasomotor responses of blood vessels in rabbit ear to electrical stimulation.

Authors:  Ying-Ying Chen; Jun Lv; Xiao-Yan Xue; Gong-Hao He; Ying Zhou; Min Jia; Xiao-Xing Luo
Journal:  Neurosci Bull       Date:  2010-06       Impact factor: 5.203

Review 3.  Central nervous system biogenic amine targets for control of appetite and energy expenditure.

Authors:  David L Nelson; Donald R Gehlert
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

4.  Compared pharmacology of human histamine H3 and H4 receptors: structure-activity relationships of histamine derivatives.

Authors:  Florence Gbahou; Ludwig Vincent; Marie Humbert-Claude; Joel Tardivel-Lacombe; Claude Chabret; Jean-Michel Arrang
Journal:  Br J Pharmacol       Date:  2006-04       Impact factor: 8.739

5.  Marked changes in signal transduction upon heteromerization of dopamine D1 and histamine H3 receptors.

Authors:  Carla Ferrada; Estefanía Moreno; Vicent Casadó; Gerold Bongers; Antoni Cortés; Josefa Mallol; Enric I Canela; Rob Leurs; Sergi Ferré; Carme Lluís; Rafael Franco
Journal:  Br J Pharmacol       Date:  2009-05       Impact factor: 8.739

Review 6.  Molecular and biochemical pharmacology of the histamine H4 receptor.

Authors:  Rob Leurs; Paul L Chazot; Fiona C Shenton; Herman D Lim; Iwan J P de Esch
Journal:  Br J Pharmacol       Date:  2009-05       Impact factor: 8.739

7.  Interactions between histamine H3 and dopamine D2 receptors and the implications for striatal function.

Authors:  Carla Ferrada; Sergi Ferré; Vicent Casadó; Antonio Cortés; Zuzana Justinova; Chanel Barnes; Enric I Canela; Steven R Goldberg; Rob Leurs; Carme Lluis; Rafael Franco
Journal:  Neuropharmacology       Date:  2008-05-16       Impact factor: 5.250

8.  Therapeutic potential of histamine H₄ receptor agonists in triple-negative human breast cancer experimental model.

Authors:  Diego J Martinel Lamas; Maximo Croci; Eliana Carabajal; Ernesto J V Crescenti; Lorena Sambuco; Noelia A Massari; Rosa M Bergoc; Elena S Rivera; Vanina A Medina
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

9.  Sequential engagement of FcεRI on Mast Cells and Basophil Histamine H(4) Receptor and FcεRI in Allergic Rhinitis.

Authors:  Yoshiki Shiraishi; Yi Jia; Joanne Domenico; Anthony Joetham; Hajime Karasuyama; Katsuyuki Takeda; Erwin W Gelfand
Journal:  J Immunol       Date:  2012-12-14       Impact factor: 5.422

10.  Role of a histamine 4 receptor as an anti-inflammatory target in carrageenan-induced pleurisy in mice.

Authors:  Sheikh Fayaz Ahmad; Khairy M A Zoheir; Hala E Abdel-Hamied; Ibrahim Alrashidi; Sabry M Attia; Saleh A Bakheet; Abdelkader E Ashour; Adel R A Abd-Allah
Journal:  Immunology       Date:  2014-07       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.